Cite

    Uemoto, S. et al. (n.d.). Advantage of tacrolimus/mycophenolate mofetil regimen for cytotoxic T cell-mediated defence and its inhibition by additive steroid administration in high-risk liver transplant recipients. Clinical and experimental immunology. pp. 126-136. [Online].